osiris therapeutics inc (OSIR:NASDAQ GM)
Jay M. Moyes MBA
Independent Director, Chairman of Audit Committee and Member of Nominating Committee, Osiris Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 21 board members in 4 different organizations across 7 different industries.|
See Board Relationships
Mr. Jay M. Moyes, MBA served as the Chief Financial Officer at Amedica Corporation from October 2013 to August 7, 2014 and served as its Principal Accounting Officer until August 7, 2014. Mr. Moyes served as Chief Financial Officer of XDx, Inc. since May 2008. Mr. Moyes served as the Chief Financial Officer and Treasurer of Myriad Genetics Inc., from June 1996 to November 1, 2007 and served as its Principal Accounting Officer and Assistant Secretary until November 1, ...
7015 Albert Einstein DrivePhone: 443-545-1800
Columbia, Maryland 21046
Board Members Memberships*
Independent Director, Chairman of Audit Committee and Member of Nominating Committee
Former Chief Financial Officer, Principal Accounting Officer and Director
Director, Chairman of Compensation Committee, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
The University of Utah
Weber State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Thomas Axelsson M.Sc.||Chief Executive Officer|
Vitrolife AB (publ)
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Ocata Therapeutics, Inc.
|Silviu Itescu MBBS (Hons), FRACP, FACP, FACR, FTSE||Founder, Chairman of Scientific Advisory Board, Chief Executive Officer, Managing Director, Executive Director and Member of Science & Technology Committee|
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$362.9K||Compensation as of Fiscal Year 2013.|